Funding for this research was provided by:
Ministero della Salute (NET-2011-02346784, CTN01_00177_165430, RF-2010e2309849)
FP7 Health (259867, 278850)
Fondazione Cariplo (2014-0832)
Ministero dell’Istruzione, dell’Università e della Ricerca (Joint Programme–Neurodegenerative Disease Research (Sophia Project, MIUR project "Dipartimenti di Eccellenza 2018 – 2022")
Eli Lilly Foundation (Imaging of neuroinflammation and neurodegeneration in prodromal and presymptomatic Alzheimer's disease phases)
Fondazione Vialli e Mauro (-)
Fondazione Magnetto (-)
Text and Data Mining valid from 2019-01-07
Received: 12 September 2018
Accepted: 19 December 2018
First Online: 7 January 2019
Compliance with ethical standards
: A. Chiò reports grants from the Italian Ministry of Health (Ricerca Finalizzata), EU JPND through the Ministry of Education, University, and Research, and the Italy-Israel Scientific Collaboration through the Italian Foreign Ministry, as well as personal fees from Biogen Idec, Cytokinetics, Italfarmaco, Mitsubishi Tanabe, and Neuraltus. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.